Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

High costs and limited access threaten progress in HIV treatment despite new drug advances, says GlobalData

Despite major strides in antiretroviral therapy (ART), the human immunodeficiency virus (HIV) market still faces serious challenges that threaten long-term control of the disease. The most pressing issue is the lack of affordable access to newer therapies, which—despite offering better adherence and fewer side effects—remain out of reach for many patients due to high costs […]
Read more

Vutrisiran to change ATTR-CM treatment paradigm in Europe, says GlobalData

Transthyretin amyloidosis (ATTR) is a protein conformational disorder caused by the build-up of transthyretin, the protein carrying thyroxine and retinol in the bloodstream. It can cause ATTR-cardiomyopathy (ATTR-CM) or ATTR-polyneuropathy (ATTR-PN). As effective treatments for ATTR-CM are still limited, Alnylam Pharmaceuticals’ drug vutrisiran is expected to change ATTR-CM treatment paradigm upon market launch in Europe, […]
Read more

Nontuberculous mycobacteria market to reach $4.6 billion in 7MM in 2033, forecasts GlobalData

The nontuberculous mycobacteria (NTM) market across the seven major markets (7MM*) is forecast to grow at a compound annual growth rate (CAGR) of 8.8% from $2.0 billion in 2023 to $4.6 billion in 2033, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, “Nontuberculous Mycobacteria (NTM): Opportunity Assessment and Forecast”, reveals that […]
Read more

New CGM-enabled insulin delivery systems address demand for automated diabetes care, says GlobalData

With around 2 million Americans living with type 1 diabetes, and an increasing number of insulin-requiring type 2 cases, the US healthcare system is experiencing growing demand for simplified, automated diabetes care. The integration of Abbott Laboratories’ FreeStyle Libre 3 Plus continuous glucose monitor (CGM) with the Tandem t:slim X2 insulin pump system marks a […]
Read more

Diagnosed prevalent cases of multiple sclerosis to increase by 0.19% AGR in 7MM during 2024-34, forecasts GlobalData

The diagnosed prevalent cases of multiple sclerosis (MS) in the seven major markets (7MM*) are projected to increase from 1.61 million in 2024 to 1.64 million in 2034 at an annual growth rate (AGR) of negative 0.19%, forecasts GlobalData, a leading data and analytics company. GlobalData’s latest report, “Multiple Sclerosis Epidemiology Analysis and Forecast to […]
Read more

UK health & beauty specialists lose out to discounters in value for money rankings, finds GlobalData

UK health & beauty specialists are struggling to compete with low-priced discounters, as consumers are not recognizing the additional value for money that comes from their better ranges, product quality, and service. With personal finances still recovering from the impact of inflationary pressure, consumers still prefer to shop at discounters for essentials, according to GlobalData, […]
Read more
1 … 69 70 71 72 73 … 784